Edition:
United States

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

6.67USD
25 May 2018
Change (% chg)

$0.02 (+0.30%)
Prev Close
$6.65
Open
$6.63
Day's High
$6.67
Day's Low
$6.63
Volume
381
Avg. Vol
2,518
52-wk High
$10.75
52-wk Low
$4.61

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 243.17 32.94
P/E High - Last 5 Yrs. -- 292.19 47.16
P/E Low - Last 5 Yrs. -- 100.20 24.79
Beta -- 0.75 0.78
Price to Sales (TTM) -- 250.73 8.13
Price to Book (MRQ) -- 24.24 4.34
Price to Tangible Book (MRQ) -- 27.23 5.84
Price to Cash Flow (TTM) -- 138.95 22.00
% Owned Institutions -- 10.82 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.65
Dividend Yield - 5 Year Avg -- 0.20 0.79
Dividend 5 Year Growth Rate -- 2.32 4.02
Payout Ratio(TTM) -- 46.60 17.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.35 5.00
Sales (TTM) vs TTM 1 Yr. Ago -- 146.21 12.76
Sales - 5 Yr. Growth Rate -- 30.96 8.13
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -92.15 35.26
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 48.60 8.59
Capital Spending - 5 Yr. Growth Rate -- 40.09 8.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.53
Current Ratio (MRQ) -- 6.56 3.61
LT Debt to Equity (MRQ) -- 22.15 12.75
Total Debt to Equity (MRQ) -- 25.59 15.82
Interest Coverage (TTM) -- -176.29 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 54.92
Gross Margin - 5 Yr. Avg. -- 55.13 52.70
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -151.01 15.95
Operating Margin (TTM) -- -874.91 0.17
Operating Margin - 5 Yr. Avg. -- -163.69 11.24
Pre-Tax Margin (TTM) -- -763.70 2.21
Pre-Tax Margin - 5 Yr. Avg. -- -168.55 11.46
Net Profit Margin (TTM) -- -755.33 -1.22
Net Profit Margin - 5 Yr. Avg. -- -168.17 7.75
Effective Tax Rate (TTM) -- 14.79 31.16
Effective Tax Rate - 5 Yr. Avg. -- 19.57 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,221,672 732,879,315
Net Income/Employee (TTM) -- -806,425 85,224,914
Receivable Turnover (TTM) -- 17.43 5.88
Inventory Turnover (TTM) -- 2.45 3.58
Asset Turnover (TTM) -- 0.42 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -5.15 10.13
Return on Assets - 5 Yr. Avg. -- -0.29 11.15
Return on Investment (TTM) -- -7.30 12.79
Return on Investment - 5 Yr. Avg. -- 3.03 14.43
Return on Equity (TTM) -- -10.05 14.67
Return on Equity - 5 Yr. Avg. -- -2.71 15.77

Performance for BiondVax Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.